Pallas Capital Advisors LLC lifted its stake in Molina Healthcare, Inc. (NYSE:MOH - Free Report) by 252.5% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 7,259 shares of the company's stock after purchasing an additional 5,200 shares during the period. Pallas Capital Advisors LLC's holdings in Molina Healthcare were worth $2,391,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also recently modified their holdings of the company. Mirae Asset Global Investments Co. Ltd. boosted its holdings in Molina Healthcare by 29.9% in the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 6,545 shares of the company's stock worth $1,909,000 after buying an additional 1,506 shares during the period. Choreo LLC boosted its holdings in shares of Molina Healthcare by 7.7% during the 4th quarter. Choreo LLC now owns 1,115 shares of the company's stock valued at $323,000 after purchasing an additional 80 shares during the last quarter. Sumitomo Mitsui Trust Group Inc. boosted its holdings in shares of Molina Healthcare by 2.2% during the 4th quarter. Sumitomo Mitsui Trust Group Inc. now owns 149,573 shares of the company's stock valued at $43,533,000 after purchasing an additional 3,238 shares during the last quarter. Empirical Finance LLC boosted its holdings in shares of Molina Healthcare by 53.8% during the 4th quarter. Empirical Finance LLC now owns 4,632 shares of the company's stock valued at $1,348,000 after purchasing an additional 1,621 shares during the last quarter. Finally, Entropy Technologies LP boosted its holdings in shares of Molina Healthcare by 58.1% during the 4th quarter. Entropy Technologies LP now owns 4,594 shares of the company's stock valued at $1,337,000 after purchasing an additional 1,688 shares during the last quarter. 98.50% of the stock is currently owned by hedge funds and other institutional investors.
Insider Activity
In other Molina Healthcare news, CEO Joseph M. Zubretsky sold 87,500 shares of the firm's stock in a transaction that occurred on Wednesday, April 30th. The shares were sold at an average price of $320.06, for a total value of $28,005,250.00. Following the completion of the sale, the chief executive officer now directly owns 257,715 shares in the company, valued at $82,484,262.90. This trade represents a 25.35% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Richard M. Schapiro sold 669 shares of the firm's stock in a transaction that occurred on Tuesday, April 29th. The shares were sold at an average price of $320.50, for a total transaction of $214,414.50. Following the completion of the sale, the director now owns 11,244 shares of the company's stock, valued at approximately $3,603,702. This trade represents a 5.62% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 1.26% of the company's stock.
Molina Healthcare Trading Up 1.7%
Shares of NYSE:MOH traded up $4.91 during trading on Friday, reaching $298.39. 630,608 shares of the company were exchanged, compared to its average volume of 686,529. The firm has a market capitalization of $16.17 billion, a PE ratio of 14.61, a P/E/G ratio of 1.06 and a beta of 0.57. The business's fifty day simple moving average is $316.10 and its 200-day simple moving average is $307.20. Molina Healthcare, Inc. has a 12-month low of $262.32 and a 12-month high of $365.23. The company has a debt-to-equity ratio of 0.69, a current ratio of 1.62 and a quick ratio of 1.62.
Molina Healthcare (NYSE:MOH - Get Free Report) last issued its earnings results on Wednesday, April 23rd. The company reported $6.08 EPS for the quarter, topping analysts' consensus estimates of $5.96 by $0.12. The business had revenue of $11.15 billion for the quarter, compared to analyst estimates of $10.86 billion. Molina Healthcare had a net margin of 2.90% and a return on equity of 28.13%. The company's quarterly revenue was up 12.2% compared to the same quarter last year. During the same period last year, the company posted $5.73 earnings per share. On average, research analysts anticipate that Molina Healthcare, Inc. will post 24.4 EPS for the current year.
Wall Street Analyst Weigh In
Several research analysts have commented on MOH shares. Barclays dropped their price objective on shares of Molina Healthcare from $351.00 to $347.00 and set an "equal weight" rating for the company in a report on Monday. Sanford C. Bernstein began coverage on shares of Molina Healthcare in a report on Tuesday, April 22nd. They set an "outperform" rating and a $414.00 price objective for the company. Wells Fargo & Company raised shares of Molina Healthcare from an "equal weight" rating to an "overweight" rating and increased their price target for the company from $295.00 to $372.00 in a report on Wednesday, March 5th. Baird R W downgraded shares of Molina Healthcare from a "strong-buy" rating to a "hold" rating in a report on Tuesday, April 15th. Finally, Truist Financial increased their price target on shares of Molina Healthcare from $340.00 to $400.00 and gave the company a "buy" rating in a report on Friday, April 11th. Nine analysts have rated the stock with a hold rating and eight have given a buy rating to the company. Based on data from MarketBeat, Molina Healthcare presently has a consensus rating of "Hold" and an average target price of $364.21.
Check Out Our Latest Stock Report on MOH
Molina Healthcare Company Profile
(
Free Report)
Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.
Featured Articles

Before you consider Molina Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Molina Healthcare wasn't on the list.
While Molina Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.